Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes with Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients with Chronic Lymphocytic Leukemia from Senegal

Abibatou Sall, MDPhD, Teresa Amato, MB, PhD, Alessandro Gozzetti, Awa Oumar Touré, MD PhD, Saliou Diop, MD MSc, Lorenzo Leoncini, Pier Paolo Piccaluga, MD PhD, Martine Raphaël, MD PhD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-138827

Published: 2020

Journal Articles

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-137727

Published: 2020

Journal Articles

Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML

Blood (2015) 126 (23): 329.

https://doi.org/10.1182/blood.V126.23.329.329

Published: 2015

Journal Articles

IGH-FR1 and Leader Analysis By Next Generation Sequencing for the Detection of Clonality and Somatic Hypermutation in Lymphoid Malignancies

Pier Paolo Piccaluga, MD PhD, Anna Gazzola, PhD, Ying Huang, Jeff Panganiban, Kasey Hutt, Michael Klass

Blood (2015) 126 (23): 3868.

https://doi.org/10.1182/blood.V126.23.3868.3868

Published: 2015

Journal Articles

Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 1675.

https://doi.org/10.1182/blood.V126.23.1675.1675

Published: 2015

Journal Articles

Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from Miseq NGS Vs PCR-Sanger Sequencing Approaches

Ying Huang, PhD, Kasey Hutt, PhD, Jeff Panganiban, BS, Jeffrey Edward Miller, PhD, Jordan Thornes, BS, Anna Gazzola, PhD, Pier Paolo Piccaluga, MD PhD, Michael Klass, PhD

Blood (2014) 124 (21): 3317.

https://doi.org/10.1182/blood.V124.21.3317.3317

Published: 2014

Journal Articles

Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi

Francesco Zaja, Flavia Salvi, MD, Silvia Franceschetti, Gianluca Gaidano, Marco Ladetto, Manuela Zanni, Gian Matteo Pica, Angelo Michele Carella, Annalisa Chiappella, Stefano Volpetti, Pier Luigi Zinzani, Alfonso Maria D'Arco, Andrea Evangelista, Alessandra Tucci, Pier Paolo Piccaluga, MD, PhD, Stefano A. Pileri, Renato Fanin, MD, Alessandro Levis

Blood (2013) 122 (21): 3047.

https://doi.org/10.1182/blood.V122.21.3047.3047

Published: 2013

Journal Articles

Molecular Profiling Of Blastic Plasmacytoid Dendritic CELL Neoplasm Reveals A Unique Pattern and Suggests Selective Sensitivity To NF-KB Pathway Inhibition

Blood (2013) 122 (21): 2502.

https://doi.org/10.1182/blood.V122.21.2502.2502

Published: 2013

Journal Articles

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

Alessandro Isidori, MD, PhD, Annamaria Ruzzo, PhD, Federica Loscocco, Maria Teresa Voso, M.D., Francesco Graziano, Sara Barulli, Emanuele Canestrari, Antonio Volpe, MD, Domenico Magro, MD, Pier Paolo Piccaluga, MD, PhD, Fabio Fuligni, Stefania Paolini, Teresa Ricciardi, Paola Picardi, Elisa Giacomini, Marco Rocchi, Mauro Magnani, Giuseppe Visani, MD

Blood (2013) 122 (21): 2815.

https://doi.org/10.1182/blood.V122.21.2815.2815

Published: 2013

Journal Articles

The Combination Of Hypomethylating Agents and Histone Deacetylase Inhibitors(HDACi) Are Synergistically Cytotoxic and Reverse The Malignant Phenotype In Preclinical Models Of T-Cell Lymphoma

Owen A. O'Connor, MD, PhD, Enrica Marchi, MD, PhD, Kelly Zullo, BS, Luigi Scotto, PhD, Jennifer E. Amengual, MD, Fabio Fuligni, Pier Luigi Zinzani, MD, Stefano A. Pileri, Pier Paolo Piccaluga, MD, PhD

Blood (2013) 122 (21): 646.

https://doi.org/10.1182/blood.V122.21.646.646

Published: 2013

Journal Articles

Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance

Blood (2013) 122 (21): 741.

https://doi.org/10.1182/blood.V122.21.741.741

Published: 2013

Journal Articles

Gene Expression Analysis of Follicular Lymphoma Provides a Potential Rationale for Histological Grading Revision.

Pier Paolo Piccaluga, MD, PhD, Andrea Califano, PhD, Ulf Klein, PhD, Claudio Agostinelli, MD, Beartiz Bellosillo, MD, Eva Gimeno, MD, Sergi Serrano, MD, Francisco Solè, MD, Yonghui Zang, PhD, Brunangelo Falini, MD, Pier Luigi Zinzani, MD, Stefano A. Pileri, MD

Blood (2007) 110 (11): 186.

https://doi.org/10.1182/blood.V110.11.186.186

Published: 2007

Journal Articles

Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.

Pier Paolo Piccaluga, MD, PhD, Philip Went, MD, Claudio Agostinelli, MD, Andrea Gallamini, MD, Stefano Ascani, MD, Elena Sabattini, MD, Francesco Bacci, MD, Brunangelo Falini, MD, Teresio Motta, MD, Marco Paulli, MD, Tullio Artusi, MD, Pier Luigi Zinzani, MD, Michele Baccarani, MD, Stefano A. Pileri, MD, on Behalf of the Intergruppo Italiano Linfomi

Blood (2005) 106 (11): 2819.

https://doi.org/10.1182/blood.V106.11.2819.2819

Published: 2005

Journal Articles

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Pier-Paolo Piccaluga, MD, PhD, Claudio Agostinelli, MD, Simona Zupo, MD, Andrea Califano, PhD, Philip Went, MD, Stefano Ascani, MD, Katia Basso, PhD, Fabio Facchetti, MD, Brunangelo Falini, MD, Manlio Ferrarini, MD, Andrea Gallamini, MD, Ulf Klein, PhD, Domenico Novero, MD, Marco Paulli, MD, Sante Tura, MD, Pier Luigi Zinzani, MD, Michele Baccarani, MD, Riccardo Dalla-Favera, MD, Stefano A. Pileri, MD

Blood (2005) 106 (11): 1217.

https://doi.org/10.1182/blood.V106.11.1217.1217

Published: 2005

NARROW

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes with Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients with Chronic Lymphocytic Leukemia from Senegal

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML

IGH-FR1 and Leader Analysis By Next Generation Sequencing for the Detection of Clonality and Somatic Hypermutation in Lymphoid Malignancies

Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes

Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from Miseq NGS Vs PCR-Sanger Sequencing Approaches

Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi

Molecular Profiling Of Blastic Plasmacytoid Dendritic CELL Neoplasm Reveals A Unique Pattern and Suggests Selective Sensitivity To NF-KB Pathway Inhibition

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

The Combination Of Hypomethylating Agents and Histone Deacetylase Inhibitors(HDACi) Are Synergistically Cytotoxic and Reverse The Malignant Phenotype In Preclinical Models Of T-Cell Lymphoma

Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance

Gene Expression Analysis of Follicular Lymphoma Provides a Potential Rationale for Histological Grading Revision.

Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only